MCMedicalCodingSoftware
3E0P70M

3E0P70MIntroduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce of Antneo, Moncln Ab, into Fem Reprod, Via Opening

How 3E0P70M is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. PBody partThe specific site
  5. 7ApproachHow the site was reached
  6. 0DeviceWhat was left in place, if anything
  7. MQualifierA further distinction where one applies

Codes near 3E0P70M

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0P3Q1Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Percutaneous Approach
  • 3E0P3SFIntroduction of Other Gas into Female Reproductive, Percutaneous Approach
  • 3E0P3TZIntroduction of Destructive Agent into Female Reproductive, Percutaneous Approach
  • 3E0P3VZIntroduction of Hormone into Female Reproductive, Percutaneous Approach
  • 3E0P45ZIntroduction of Adhesion Barrier into Female Reproductive, Percutaneous Endoscopic Approach
  • 3E0P4GCIntroduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Endoscopic Approach
  • 3E0P704Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P705Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P70MIntroduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P728Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P729Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P73ZIntroduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P76ZIntroduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P77ZIntroduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P7BZIntroduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P7GCIntroduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P7HZIntroduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening
ICD-10-PCSFY2026